Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Shooter 

Teva Pharmaceutical Industries Ltd ADR diskutieren

Teva Pharmaceutical Industries Ltd ADR

WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Aktie / Pharmazeutika / Large Cap /

25,50 €
-1,16 %

Einschätzung Buy
Rendite (%) 49,71 %
Kursziel 22,18
Veränderung
Endet am 03.10.26

Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at JPMorgan Chase & Co. from $23.00 to $26.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,63 %
Kursziel 24,33
Veränderung
Endet am 06.11.26

Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at JPMorgan Chase & Co. from $26.00 to $28.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,51 %
Kursziel 26,60
Veränderung
Endet am 08.12.26

Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,40 %
Kursziel 30,05
Veränderung
Endet am 09.12.26

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $35.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,07 %
Kursziel 27,48
Veränderung
Endet am 09.12.26

Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Bank of America Corporation from $29.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat